secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeoVax Labs, Inc. (GOVX)
CIK:        0000832489
Form:       8-K
Filed at:   2026-09-10T20:35:22+00:00
Accession:  0001437749-26-030085
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeoVax faces Nasdaq delisting hearing Oct 13 over bid price; stock continues trading
--------------------------------------------------------------------------------

- Received Nasdaq delisting determination Aug 27, 2026 for failing minimum bid price (Rule 5550(a)(2)).
- Hearing before Nasdaq Hearings Panel scheduled for Oct 13, 2026; suspension/delisting stayed pending hearing.
- Common stock continues trading on Nasdaq Capital Market under GOVX through hearing and any extension.
- Company to present plan to regain compliance; reaffirms GEO-MVA pivotal Phase 3 and Gedeptin oncology progress.
- CEO David Dodd cites vaccine supply resilience and biodefense preparedness as strategic focus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832489/000143774926030085/0001437749-26-030085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832489/000143774926030085/govx20260909_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-030085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer